Appleton Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.7M Sell
45,874
-708
-2% -$165K 0.71% 41
2026
Q1
$11.4M Sell
46,582
-606
-1% -$141K 0.79% 37
2025
Q4
$9.77M Buy
47,188
+179
+0.4% +$35.4K 0.64% 51
2025
Q3
$8.72M Buy
47,009
+29
+0.1% +$4.97K 0.59% 59
2025
Q2
$7.18M Sell
46,980
-1,065
-2% -$164K 0.51% 67
2025
Q1
$7.97M Sell
48,045
-1,872
-4% -$293K 0.62% 55
2024
Q4
$7.22M Sell
49,917
-5,330
-10% -$826K 0.53% 63
2024
Q3
$8.95M Sell
55,247
-1,112
-2% -$177K 0.66% 53
2024
Q2
$8.24M Sell
56,359
-1,049
-2% -$156K 0.63% 52
2024
Q1
$9.08M Sell
57,408
-3,030
-5% -$482K 0.7% 47
2023
Q4
$9.47M Buy
60,438
+1,184
+2% +$182K 0.76% 41
2023
Q3
$9.23M Sell
59,254
-1,482
-2% -$245K 0.82% 33
2023
Q2
$10.1M Buy
60,736
+283
+0.5% +$45.7K 0.85% 31
2023
Q1
$9.37M Buy
60,453
+859
+1% +$139K 0.83% 30
2022
Q4
$10.5M Sell
59,594
-96
-0.2% -$16.6K 1% 27
2022
Q3
$9.75M Buy
59,690
+189
+0.3% +$32K 0.98% 26
2022
Q2
$10.6M Sell
59,501
-952
-2% -$170K 1% 28
2022
Q1
$10.7M Sell
60,453
-1,443
-2% -$246K 0.88% 31
2021
Q4
$10.6M Sell
61,896
-449
-0.7% -$73.5K 0.8% 35
2021
Q3
$10.1M Sell
62,345
-803
-1% -$137K 0.84% 34
2021
Q2
$10.4M Sell
63,148
-1,554
-2% -$257K 0.89% 30
2021
Q1
$10.6M Sell
64,702
-1,089
-2% -$176K 0.99% 28
2020
Q4
$10.4M Sell
65,791
-349
-0.5% -$51.5K 1.02% 30
2020
Q3
$9.85M Sell
66,140
-265
-0.4% -$39.2K 1.09% 28
2020
Q2
$9.34M Sell
66,405
-7,307
-10% -$1.06M 1.12% 28
2020
Q1
$9.67M Sell
73,712
-3,762
-5% -$534K 1.34% 18
2019
Q4
$11.3M Buy
77,474
+2,615
+3% +$355K 1.24% 20
2019
Q3
$9.69M Buy
74,859
+883
+1% +$116K 1.17% 25
2019
Q2
$10.3M Buy
73,976
+1,508
+2% +$209K 1.27% 18
2019
Q1
$10.1M Buy
72,468
+298
+0.4% +$39.9K 1.34% 17
2018
Q4
$9.31M Buy
72,170
+3,021
+4% +$421K 1.39% 15
2018
Q3
$9.55M Sell
69,149
-114
-0.2% -$15.1K 1.27% 17
2018
Q2
$8.4M Buy
69,263
+1,453
+2% +$181K 1.2% 21
2018
Q1
$8.69M Buy
67,810
+1,206
+2% +$163K 1.32% 16
2017
Q4
$9.31M Sell
66,604
-22
-0% -$3.06K 1.44% 12
2017
Q3
$8.66M Sell
66,626
-1,299
-2% -$172K 1.46% 12
2017
Q2
$8.99M Sell
67,925
-698
-1% -$89K 1.51% 12
2017
Q1
$8.55M Sell
68,623
-2,788
-4% -$333K 1.57% 9
2016
Q4
$8.23M Sell
71,411
-1,698
-2% -$196K 1.66% 12
2016
Q3
$8.64M Sell
73,109
-2,116
-3% -$257K 1.63% 12
2016
Q2
$9.13M Sell
75,225
-1,674
-2% -$190K 1.87% 9
2016
Q1
$8.32M Sell
76,899
-583
-0.8% -$60.4K 1.64% 13
2015
Q4
$7.96M Buy
77,482
+1,162
+2% +$117K 1.57% 13
2015
Q3
$7.12M Buy
76,320
+4,362
+6% +$422K 1.62% 14
2015
Q2
$7.01M Sell
71,958
-1,282
-2% -$128K 1.57% 19
2015
Q1
$7.37M Sell
73,240
-1,708
-2% -$174K 1.66% 16
2014
Q4
$7.84M Buy
74,948
+584
+0.8% +$61.5K 1.79% 14
2014
Q3
$7.93M Buy
74,364
+1,265
+2% +$131K 1.85% 10
2014
Q2
$7.65M Sell
73,099
-96
-0.1% -$9.7K 1.79% 12
2014
Q1
$7.19M Buy
73,195
+346
+0.5% +$32.1K 1.7% 15
2013
Q4
$6.67M Buy
72,849
+1,513
+2% +$139K 1.6% 23
2013
Q3
$6.18M Sell
71,336
-830
-1% -$74.5K 1.66% 20
2013
Q2
$6.2M Buy
+72,166
New +$6.12M 1.79% 21

Other funds holding JNJ

Appleton Partners's JNJ Position: Q2 2026 in Review

Appleton Partners reduced its Johnson & Johnson (JNJ) stake by 1.5% in Q2 2026, selling an estimated $165K and leaving 45,874 shares worth $11.7M. The position accounts for 0.71% of the portfolio, ranked #41.

Appleton Partners first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 1,207 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Appleton Partners held 45,874 shares of Johnson & Johnson worth $11.7M as of Q2 2026.
  • Appleton Partners sold 708 Johnson & Johnson shares in Q2 2026, an estimated $165K.
  • Johnson & Johnson made up 0.71% of Appleton Partners's portfolio in Q2 2026, its #41 holding.
  • Appleton Partners first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 1,207 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Appleton Partners's 13F filing for Q2 2026, filed 21 Jul 2026.